Previous reports have shown that blood sPD-L1 levels are increased and associated with disease activities in various autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, autoimmune hepatitis, systemic sclerosis, and immune thrombocytopenia27–31. Here, SPDL1 is linked to autoimmune hepatitis.